Sex Differences in Intimate Partner Violence Lethality Risk Screening Administration and Outcomes

This cross-sectional study of sex differences in IPV-related lethality screening found sex-based differences in the administration and clinical outcomes of IPV-related lethality screening among patients screened for IPV during health care encounters. Nearly 1 in 5 men were misclassified as negative for IPV and, therefore, not administered the IPV-related lethality screen per protocol. Among patients who received the second screen, lethality risk was significantly higher for women across all screening items compared with men. Further research is needed to assess IPV experiences among men, including gaps in health care and opportunities to improve implementation of IPV screening and response for men, as well as to identify effective strategies for connecting all patients at risk of lethal IPV to lifesaving services.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-12-03
DOI
https://doi.org/10.1001/jamanetworkopen.2025.45519
Citations
1
Primary Topic
Intimate Partner and Family Violence
Type
article
Field-Weighted Citation Impact
2.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sex Differences in Intimate Partner Violence Lethality Risk Screening Administration and Outcomes

Katherine M. Iverson, Melissa E. Dichter, Mark Relyea, Jacquelyn C. Campbell et al.
1 citations
JAMA Network Open
Intimate Partner and Family Violence
2.17
article

Sex Differences in Intimate Partner Violence Lethality Risk Screening Administration and Outcomes

Katherine M. Iverson, Melissa E. Dichter, Mark Relyea, Jacquelyn C. Campbell, Cynthia Brandt, Galina A. Portnoy, Elizabeth C. Coppola, LeAnn E. Bruce
article en
1 citations

Abstract

This cross-sectional study of sex differences in IPV-related lethality screening found sex-based differences in the administration and clinical outcomes of IPV-related lethality screening among patients screened for IPV during health care encounters. Nearly 1 in 5 men were misclassified as negative for IPV and, therefore, not administered the IPV-related lethality screen per protocol. Among patients who received the second screen, lethality risk was significantly higher for women across all screening items compared with men. Further research is needed to assess IPV experiences among men, including gaps in health care and opportunities to improve implementation of IPV screening and response for men, as well as to identify effective strategies for connecting all patients at risk of lethal IPV to lifesaving services.

JAMA Network OpenVol. 8(12)
Boston University (US), Johns Hopkins University (US), VA Boston Healthcare System (US), Yale University (US), VA Connecticut Healthcare System (US), National Center for PTSD (US), Philadelphia VA Medical Center (US), Temple University (US), Western Kentucky University (US)
U.S. Department of Veterans Affairs, Health Services Research and Development, Quality Enhancement Research Initiative
Openalex Percentile: Top 10%
Intimate Partner and Family Violence
2.17
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Sex Differences in Intimate Partner Violence Lethality Risk Screening Administration and Outcomes — Katherine M. Iverson, Melissa E. Dichter, et al. · JAMA Network Open (2025) | TGRS Research Map | TGRS